Welcome to our dedicated page for Inverse VIX S/T Futs ETNs due Mar22,2045 SEC filings (Ticker: VYLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Inverse VIX S/T Futs ETNs due Mar22,2045's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Inverse VIX S/T Futs ETNs due Mar22,2045's regulatory disclosures and financial reporting.
J.P. Morgan is marketing 5-year “Uncapped Buffered Return Enhanced Notes” linked to the MSCI EAFE® Index (MXEA). The notes will be issued by JPMorgan Chase Financial Company LLC and fully guaranteed by JPMorgan Chase & Co. Key dates are a Pricing Date of 30 Jun 2025, a single Observation Date of 1 Jul 2030, and a Maturity Date of 5 Jul 2030. Minimum investment is $1,000 (CUSIP 48136E6Q3).
Return profile
- Upside is uncapped and multiplied by an Upside Leverage Factor ≥ 1.195 (final factor set on the pricing date).
- A 20 % downside buffer means investors receive full principal if the index is flat or falls by ≤ 20 %.
- If the index declines by > 20 %, principal is reduced 1-for-1 beyond the buffer: Payment = $1,000 + [$1,000 × (Index Return + 20 %)]
Valuation metrics
- Estimated value at issuance ≥ $920 per $1,000 note, reflecting internal funding costs; secondary-market prices may differ.
- No periodic coupons, dividends, or voting rights.
Principal risks highlighted
- Credit risk of both the issuer and guarantor.
- Market risk tied to non-U.S. equities and FX movements embedded in the MSCI EAFE index.
- Liquidity risk: JP Morgan Securities LLC may make a market but is not obliged to repurchase notes.
- Potential conflicts of interest from JP Morgan’s roles as issuer, hedger, and calculation agent.
- Possible early acceleration upon a change-in-law event.
The Free Writing Prospectus (FWP) is filed under Rule 433 (Registration Nos. 333-270004 & -01); investors should review the full preliminary pricing supplement for complete terms, risk factors, and tax disclosure.
FAQ
What is the current stock price of Inverse VIX S/T Futs ETNs due Mar22,2045 (VYLD)?
